Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03999411 · ClinicalTrials.gov registry record · Phase 4
Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients
A Phase 4 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 4
- Development phase
- 39
- Enrollment target
NCT03999411 is a Phase 4 study that has completed, run by University of Miami. The registered enrollment target is 39 participants.
The verdict
NCT03999411, a Phase 4 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to learn if a mindfulness-based smoking cessation smartphone app can help people quit smoking and stay on antiretroviral therapies.
Interventions
- DRUG Nicoderm C-Q Transdermal Product
- BEHAVIORAL Adherence to Antiretroviral Therapy Counseling
- BEHAVIORAL Behavioral Smoking Cessation Counseling
- BEHAVIORAL "Crave-to-Quit" app
- BEHAVIORAL vDOT "emocha" app
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2019-09-09 |
| Est. Completion | 2020-10-14 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03999411
The ClinicalTrials.gov registry entry for NCT03999411 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 39 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Miami, which has 721 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Nicoderm C-Q Transdermal Product is the first listed.
NCT03999411 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03999411 about?
NCT03999411 is a clinical study titled "Smartphone Intervention for Smoking Cessation and Improving Adherence to Treatment Among HIV Patients". The purpose of this study is to learn if a mindfulness-based smoking cessation smartphone app can help people quit smoking and stay on antiretroviral therapies.
What is the current status of trial NCT03999411?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 39 participants. The study started on 2019-09-09. Estimated completion is 2020-10-14.
What interventions are being tested in trial NCT03999411?
The interventions under investigation include: Nicoderm C-Q Transdermal Product (DRUG), Adherence to Antiretroviral Therapy Counseling (BEHAVIORAL), Behavioral Smoking Cessation Counseling (BEHAVIORAL), "Crave-to-Quit" app (BEHAVIORAL), vDOT "emocha" app (BEHAVIORAL).
Who is sponsoring clinical trial NCT03999411?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.